Early diagnostic value of survivin and its alternative splice variants in breast cancer.
about
Breast Cancer-Derived Extracellular Vesicles: Characterization and Contribution to the Metastatic PhenotypeThe potential of tumor-derived exosomes for noninvasive cancer monitoringLocalization and upregulation of survivin in cancer health disparities: a clinical perspectiveExtracellular vesicles: potential applications in cancer diagnosis, prognosis, and epidemiology.Evaluation of survivin splice variants in pituitary tumors.Expression of p16 and Survivin in gliomas and their correlation with cell proliferationThe emerging role of exosomes in survivin secretion.Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.Exosomes in development, metastasis and drug resistance of breast cancer.Suppressed diversity of survivin splicing in active rheumatoid arthritis.Computational Inferences of the Functions of Alternative/Noncanonical Splice Isoforms Specific to HER2+/ER-/PR- Breast Cancers, a Chromosome 17 C-HPP Study.Glioma-derived extracellular vesicles selectively suppress immune responses.Exosomes in diagnostic and therapeutic applications: biomarker, vaccine and RNA interference delivery vehicle.Tumour-derived exosomes: Tiny envelopes for big stories.Exosomes Derived from Breast Cancer Cells, Small Trojan Horses?Extracellular vesicles in breast cancer drug resistance and their clinical application.Survivin, a key player in cancer progression, increases in obesity and protects adipose tissue stem cells from apoptosis.Exosomes and breast cancer: a comprehensive review of novel therapeutic strategies from diagnosis to treatment.Exosomes in Cancer DiagnosticsPeritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy.Role of exosomal proteins in cancer diagnosisExosomal proteins as prognostic biomarkers in non-small cell lung cancerPathologic significance of a novel oncoprotein in thyroid cancer progression.Alternative Splicing in Breast Cancer and the Potential Development of Therapeutic Tools.Exosomal proteins as potential markers of tumor diagnosis.Biological Functions and Current Advances in Isolation and Detection Strategies for Exosome Nanovesicles.Exosomes: Nanocarriers of Biological Messages.Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity.The influence of tumour-derived extracellular vesicles on local and distal metastatic dissemination.The Inner and Outer Qualities of Extracellular Vesicles for Translational Purposes in Breast Cancer.Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer.Roles of Extracellular Vesicles in Metastatic Breast Cancer.Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophiesIdentification of Key Genes and Pathways in Triple-Negative Breast Cancer by Integrated Bioinformatics Analysis
P2860
Q26776113-C796148A-1D2E-448C-B15B-FED3C872FA7EQ26796396-5F00CB33-2771-4522-9AE6-DAB500655F6BQ26799719-F074FF6F-AC9C-4236-9D72-54B75546638BQ35440744-5E5AB7C4-B5AB-4495-A2AA-FE1176ABFD32Q35582889-489CCA91-6E2E-48BC-AC85-836561E76227Q35803811-4826DBD1-F351-4734-9DB5-EF588B535EB2Q35810533-B6A00011-265E-4FCC-845C-2B35A960B139Q35929423-E79C76F9-619F-4CCF-B5DA-A0CFB1D3F15AQ36016189-C1FD1F1E-CB46-49F3-A4D9-DFDEC5C2A21FQ36433351-7A89C671-767C-4C11-B880-3DF8AEA83493Q36596946-129BD192-72FD-4715-896A-C6F142422518Q36705896-9C0614FC-315F-4A20-92B0-D0F1795CE18DQ38264347-6948C3A8-64F0-4750-B765-9D3D55D02431Q38449128-4A1065DE-A3B8-4EF6-BCDA-E9B392351F8DQ38541161-6A76AFD4-BBBF-41F3-81B7-0138CF10C332Q38707369-E663D240-D476-4711-9274-748904E485C8Q38778130-A072EF55-AF45-4362-B429-FA5CE2195B1AQ39041040-FDFCBA1B-5A63-44B5-A168-9B2EEB0D5B20Q39085664-C888DE7C-2AA7-4208-8B35-DAE5B4BD4019Q39246331-B3482D83-A7BD-4D4E-8D0B-CDF5E88CBD53Q41556414-AECC967C-687B-4EBF-BBD0-5EFA77FC247EQ42282902-1760CDBD-93DA-48A5-8C75-80EEE3B2CB00Q46228906-B3ACD1C8-EAAB-49EE-B9A9-3A21C35FDDE8Q47110708-A8643FD5-FE87-42A4-9A18-46A2826A9F41Q47159665-8B35ABEE-6B06-4FA3-B88B-6B6F450480F4Q47250358-6117B157-E961-421B-A112-596BAA5CFFCEQ47763464-3EA884D6-2E94-4E99-9622-563109456B54Q47957249-C65F3BBA-0CEC-4EB7-8F1F-68E17FE2859BQ49358083-1B8844CB-8430-4C8A-91CA-BE84CEB38132Q52597634-6A25B358-D325-4C09-A400-F6C7C5C1963DQ52676618-5926FCBB-8C84-4ABF-8E3E-60C98C427367Q55035055-D406113F-55FC-4020-8707-0435AE30730BQ56936089-BD17A837-B6AF-4D58-B4F1-207675837DD8Q58803009-E2A84785-EC9A-47DD-A929-CE475477E188
P2860
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@ast
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@en
type
label
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@ast
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@en
prefLabel
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@ast
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@en
P2093
P2860
P356
P1433
P1476
Early diagnostic value of survivin and its alternative splice variants in breast cancer.
@en
P2093
David Turay
Heather Ferguson Bennit
Saied Mirshahidi
Salma Khan
P2860
P2888
P356
10.1186/1471-2407-14-176
P407
P577
2014-03-12T00:00:00Z
P5875
P6179
1045551156